desmopressin

The drug is used for the treatment of central diabetes insipidus, primary nocturnal enuresis (bedwetting) in children aged 5 years and older, as well as for the symptomatic treatment of nocturia (frequent urination at night) in adults.

Form: tablets

ATC: H01BA02

Manufacturer: Ferring International Center SA (manufacturing)

The drug is used for the treatment of central diabetes insipidus, primary nocturnal enuresis in children aged 5 years and older (with normal renal function), as well as for the symptomatic treatment of nocturia (frequent nighttime urination) in adults.

Form: tablets

ATC: H01BA02

Manufacturer: Ferring International Center SA (manufacturing)

The drug is used to treat central diabetes insipidus, as well as post-traumatic polyuria and polydipsia. It may also be used as a diagnostic tool to test the kidneys' ability to concentrate urine and for the differential diagnosis of diabetes.

Form: spray, nasal, metered

ATC: H01BA02

Manufacturer: Ferring GmbH (manufacturing, responsible for primary packaging, quality control and batch release)

The drug is used to treat central diabetes insipidus, primary nocturnal enuresis (bedwetting) in children from 5 years of age, as well as for the symptomatic treatment of nocturia (frequent urination at night) in adults.

Form: powder for oral solution

ATC: H01BA02

Manufacturer: Ferring International Center SA (secondary packaging)

The drug is used to treat central diabetes insipidus, primary nocturnal enuresis (bedwetting) in children from 5 years of age, as well as for the symptomatic treatment of nocturia (frequent urination at night) in adults.

Form: powder for oral solution

ATC: H01BA02

Manufacturer: Ferring International Center SA (secondary packaging)

The drug is used to treat central diabetes insipidus, primary nocturnal enuresis in children from 5 years of age, as well as for the symptomatic treatment of nocturia (frequent nighttime urination) in adults in combination with nocturnal polyuria.

Form: powder for oral solution

ATC: H01BA02

Manufacturer: Ferring International Center SA (secondary packaging)

The drug is used to normalize or shorten bleeding time before medical interventions, as well as to treat bleeding in cases of uremia, liver cirrhosis, platelet dysfunction, or unknown causes of bleeding. It is also used for the prevention and treatment of bleeding in mild forms of hemophilia type A and von Willebrand disease.

Form: solution for injection

ATC: H01BA02

Manufacturer: Ferring GmbH (manufacturing, primary packaging, responsible for quality control, batch release)

The drug is used to treat central diabetes insipidus, as well as polyuria (excessive urination) following trauma or surgery in the pituitary region. It is also used for diagnostic tests to assess the kidneys' ability to concentrate urine.

Form: drops, nasal

ATC: H01BA02

Manufacturer: Farmak JSC

The drug is used to treat central diabetes insipidus, as well as polyuria (excessive urination) following pituitary trauma or surgery. It is also used as a diagnostic tool to assess the kidneys' ability to concentrate urine.

Form: spray, nasal

ATC: H01BA02

Manufacturer: Farmak JSC